1005515-18-3

Upstream product

• 1005514-91-9 [3-(2-bromo-1,1-dimethoxyethyl)-5-pentafluorosulfanylphenyl]methylamine 
• 1178584-47-8 N-[3-(2-bromoacetyl)-5-(pentafluorosulfanyl)phenyl]-2,2,2-trifluoro-N-methyl-acetamide 
• 833-96-5 3-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 852469-45-5 3-nitro-5-(pentafluoro-λ⁶-sulfanyl)benzoic acid 
• 1005515-03-6 3-amino-N-methoxy-N-methyl-5-pentafluorosulfanylbenzamide 
• 1005515-04-7 N-methoxy-N-methyl-3-(pentafluorosulfanyl)-5-(2,2,2-trifluoroacetylamino)benzamide 
• 1005515-05-8 N-(3-acetyl-5-pentafluorosulfanylphenyl)-2,2,2-trifluoroacetamide 
• 1178585-39-1 N-methoxy-N-methyl-5-nitro-3-pentafluorosulfanylbenzamide 
• 1178585-27-7 1-[3-amino-5-(pentafluorosulfanyl)phenyl]ethanone 
• 1178584-95-6 N-[3-acetyl-5-(pentafluorosulfanyl)phenyl]-2,2,2-trifluoro-N-methylacetamide 
• 1005514-86-2 3-dimethylamino-5-pentafluorosulfanylbenzoic acid 
• 1005514-87-3 3-dimethylamino-N-methoxy-N-methyl-5-pentafluorosulfanylbenzamide 
• 1005514-88-4 1-(3-dimethylamino-5-pentafluorosulfanylphenyl)ethanone 
• 1005514-89-5 [3-(1,1-dimethoxyethyl)-5-pentafluorosulfanylphenyl]dimethylamine 

Downstream Products

• 1005514-65-7 6-ethoxy-3-imino-2-[2-(3-methylamino-5-pentafluorosulfanylphenyl)-2-oxoethyl]-2,3-dihydro-1H-imidazo[1,5-a]pyridin-5-one 
• 1178584-07-0 N-[3-(2-bromoacetyl)-5-(pentafluorosulfanyl)phenyl]-N-methylacetamide 
• 1180486-31-0 N-[3-[2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)acetyl]-5-(pentafluorosulfanyl)phenyl]-N-methylacetamide trifluoroacetate 

Relevant academic research and scientific papers

SF5 DERIVATIVES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R9, Ar, Q1, Q2 and Q3 are each as defined below. The compounds of the formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of the formula I and to the use thereof as a medicament.

TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where X, A?, Q1, Q2 Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated recepto

IMIDAZOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, R9, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The invention further relates to a process for preparing the compound of formula I and to the use thereof as a medicament.

TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where R1, R2, R3, R4, R5, R6, R7, R8, Q1, Q2 and Q3 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated receptor 1 (PAR1). The i

IMINO-IMIDAZO-PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY

The invention relates to compounds of the formula I having antithrombotic activity, which in particular inhibit the protease-activated receptor 1 (PAR1), processes for their preparation and use thereof as medicaments.